FB-TW

Showing posts with label Atherosclerosis. Show all posts
Showing posts with label Atherosclerosis. Show all posts

Saturday, June 28, 2014

The burden of proof in science always lies with those who propose a theory - Curtis

Evidence Against Cholesterol Causing Atherosclerosis

ernest_curtis_145by Ernest N. Curtis M.D. (Internal Medicine and Cardiology)


The burden of proof in science always lies with those who propose a theory. In this case the claim is that cholesterol is one of the chief causative agents for atherosclerosis.

Since the burden of proof is on those making the claim, we need only rebut their arguments. We don’t have to prove anything or advance an alternative theory.
The claim that cholesterol causes atherosclerosis can be rebutted on many levels. I don’t give much credence to epidemiologic evidence, but even that doesn’t pass scientific muster when it comes to cholesterol.

The correlations between cholesterol and heart attacks (the chief complication of atherosclerosis) cited in the medical literature are not even high enough to suggest an association between the two, much less a significant correlation. Even a high degree of correlation would not prove causation but the figures are nowhere near that level.

Another fly in the epidemiological soup is the fact that the incidence of heart attacks is fairly evenly distributed throughout the entire range of blood cholesterol levels. In fact more than half occur in those with cholesterol levels in the low normal range.

Many people with very high cholesterol levels live long healthy lives with no signs of complications from atherosclerosis. Conversely, many people with relatively low levels of cholesterol suffer from severe atherosclerosis and its complications. Add to that the fact that women have, on average, significantly higher cholesterol levels than men yet suffer far fewer heart attacks and I think we can conclude that the so-called evidence from epidemiology is nonexistent.

Many proponents of the cholesterol theory cite some of the statin drug trials as proof of the significance of cholesterol as an important factor by showing that reduction of its blood level provides a small degree of protection against heart attacks.

But these studies all showed a lack of normal response/exposure. There was a total disconnection between the small degree of outcome improvement and both the initial cholesterol level and the degree of cholesterol lowering attained. That is, the same small amount of benefit (which was so small as to be of no practical significance) was seen in subjects whose cholesterol declined only slightly and those in whom it declined a lot.

The benefit was also the same for those with low initial cholesterol levels and those with high initial levels. In scientific studies, this disconnection means that the factor being studied is not a cause of the outcome in question and that some other factor is at work. In this case it is possible that the anti-thrombotic action of the drug is the cause since the degree of protection against heart attack was almost identical to that seen in similar studies using aspirin or other anti-platelet drugs.

On the pathophysiologic level there are many reasons to doubt that cholesterol plays a causative role. Researchers have shown that some of the initial signs of atherosclerosis can be seen in the arteries of infants. These changes are seen in the same areas of the arteries where atherosclerotic lesions tend to occur later in life and consist of subintimal thickening with no sign of cholesterol infiltration or inflammatory reaction.

While the significance of these early changes can be debated, it is hard to deny the significance of the fact that atherosclerosis is a very focal disease process. It is found in the large and medium sized arteries and almost never in the smaller arterioles, capillaries, and veins.

Moreover, within the large and medium sized arteries there is a marked predilection for lesions to occur at branching points and along the lesser curvatures of arteries. These are areas of maximum shear stress on the arterial wall. Often one side of an arterial segment may be severely affected while the opposite wall shows no evidence of atherosclerosis whatsoever.

Atherosclerosis is often found in the arteries of the lower extremities but rarely in the arteries of the upper extremities. Atherosclerosis is never found in the veins of the body. However, veins that are subjected to arterial pressures when used as bypass grafts or arterovenous fistulas constructed for dialysis shunts often show rapid development of atherosclerosis.

These and other facts would seem to negate the possibility that atherosclerosis was caused by a chemical circulating in the blood since that should bring about a more generalized and/or random distribution of atherosclerotic lesions.

The blood flow through the larger arteries where atherosclerosis is typically found is much more rapid and laminar than it is in the smaller blood vessels. One would think that a slower flow would allow a noxious chemical to do more damage rather than less if it were a causative agent.
Einstein said that an elegant theory could be completely refuted by one inconvenient contradictory fact. In the case of cholesterol and atherosclerosis, there is a cornucopia of such facts.
Dr. Ernest N. Curtis, M.D
=================================================================
Read the complete article here.

Monday, January 13, 2014

Does Wheat Cause Coronary Heart Disease?

Does Wheat Cause Coronary Heart Disease?

Introduction

Coronary heart disease (CHD) is the leading cause of deaths worldwide - killing 7 millions people every year. In the following text, we will see that wheat consumption is probably a risk factor for CHD.

Conventional Wisdom on Wheat

Most health organizations currently view wheat as a safe food except for people having celiac disease - affecting up to 1% of the population - and people having non-celiac gluten sensitivity. Also whole wheat - as part of whole-grains - is considered to be one of the healthiest food. In fact a diet rich in whole-grains is considered to be protective against CHD.

Why? Because observational studies consistently find that whole-grain consumption is associated with a decreased risk of CHD. Do these results contradict wheat consumption causing CHD?

Are Whole-Grains Protective Against CHD?

According to this study:
Whole-grain intake consistently has been associated with improved cardiovascular disease outcomes, but also with healthy lifestyles, in large observational studies. Intervention studies that assess the effects of whole-grains on biomarkers for CHD have mixed results.
Indeed many studies show that whole-grain consumption is associated with a decreased risk of CHD. But these studies are observational and can only show correlation but not causation.

In fact there is an health-conscious population bias in these studies: for example people consuming the most whole-grains also exercise more and smoke less:
Whole-grain intake and lifestyles
Data from Majken K Jensen et al., Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men, 2004

Of course researchers adjust the data with these risk factors. But it is very difficult, maybe impossible, to adjust for all risk factors. For example the two previously cited studies did not adjust for important risk factors like socioeconomic status or social support.

A classic example of an occurrence of this bias can be found in hormone replacement therapy (HRT): observational studies had found that HRT was decreasing the risk of heart disease risk while a controlled study finally found that HRT was indeed slightly increasing the risk of heart disease.

A proof that this health-conscious bias could explain the seemingly protective effect of whole-grains can be found in randomized controlled studies: many of them fail to find any beneficial effect of whole-grains compared to refined grains.

So according to these randomized controlled studies whole-grains are neutral toward CHD risks. How then can we say that wheat causes CHD?

Are All Grains Created Equal?

Many randomized controlled studies compared wheat with other grains. These trials are usually quite short. So instead of looking at the number of heart attacks, short-term studies focus on risk predictors of CHD like weight gain or markers of inflammations. Apolipoprotein B (ApoB) level is another risk factor. It represents the number of LDL particles - often called “bad cholesterol”. It is now considered to be a better predictor than LDL-C - the amount of cholesterol contained in LDL particles. The lower the level of ApoB the lower is the risk of CHD.

Here are some results of these studies:
  • a study concluded that a bread diet may promote fat synthesis/accumulation compared with a rice diet
  • wheat increased BMI compared to flaxseed in a 12 months study
  • wheat increased ApoB level by 5.4% compared to flaxseed in a 3 weeks study
  • wheat increased ApoB level by 7.5% compared to flaxseed in a 3 months study
  • wheat increased ApoB level by 0.05 g/L compared to flaxseed in a 12 months study
  • oat decreased ApoB level by 13.7% while wheat had no significant effect in a 21 days study
  • wheat increased the number of LDL particles by 14% while oat decreased them by 5% in a 12 weeks study
  • ApoA to ApoB ratio (a risk predictor similar in efficiency to ApoB alone - here the higher the better) was increased by 4.7% for oat bran and 3.9% for rice bran compared to wheat bran in a 4 weeks study
These studies show that some grains like oat improve the risk factors of CHD compared to wheat. In addition, these studies often show an absolute improvement of the CHD risk profile in groups eating oat and an absolute deterioration in groups eating wheat. Although we cannot say for sure, it would suggest that oat is protective against CHD - which is confirmed by other studies - while wheat increase the risk of CHD.

That could help explaining why people eating more whole-grains are healthier in observational studies since it looks like that they eat more grains like rice and oat and less typically wheat-made food like white bread, pasta and doughnuts:
Whole-grain intake and different grain intakeData from Andersson A. et al., Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men, 2007

Now let’s have a look at studies linking wheat and CHD.

Observational Studies on Wheat

Some observational studies linked wheat and waist circumference gains - waist circumference being a strong predictor of CHD:
  • a study showed a correlation between consumption of white bread and waist circumference gains
  • a study concluded that: ”reducing white bread, but not whole-grain bread consumption, within a Mediterranean-style food pattern setting is associated with lower gains in weight and abdominal fat
  • a Chinese study found that ”vegetable-rich food pattern was associated with higher risk of obesity” but as noted by obesity researcher Stephan Guyenet the association between obesity is in fact stronger with wheat flour than with vegetables
A more pertinent result is found in the data of a large observational study in China. Researchers analysed these data and found a 0.67 correlation between wheat flour intake and CHD. They also found a 0.58 correlation between wheat intake and BMI.
CHD mortality and wheat intake
From Denise Minger
But this is just a single unadjusted correlation and does not prove much. However blogger Denise Minger thoroughly analysed the data of this study and found that the association held strongly after multivariate analysis with any other variable available like latitude, BMI, smoking habits, fish consumption, etc.

Since it is an observational study it cannot prove anything but it is yet another evidence suggesting that wheat consumption causes CHD. Let’s now have a look at randomized controlled trials.

Randomized Controlled Trials on Wheat

In addition to the previous randomized controlled trials comparing wheat with other grains there are two additional studies suggesting that wheat consumption causes CHD.

The first one is a study involving rabbits. While studies involving animals are not always relevant to humans - especially studies with herbivore animals like rabbit - the results of this study are quite interesting.

The researchers fed rabbits an atherogenesis diet (i.e. promoting formation of fatty masses in arterial walls) with a supplement of cottonseed oil, hydrogenated cottonseed oil, wheat germ or sucrose. And as they concludes:
Severity of atherosclerosis after 5 months was greatest on the wheat germ-supplemented diet, whereas there were no differences among the other three groups.
The second study is the Diet And Reinfarction Trial (DART). In this 2-year randomized controlled trial, people who already had recovered from an heart attack were split into groups receiving various advices. The main result of this study was that the group advised to eat fatty fish had a reduction in mortality from CHD.

One other advice - the fibre advice - was:
to eat at least six slices of wholemeal bread per day, or an equivalent amount of cereal fibre from a mixture of wholemeal bread, high-fibre breakfast cereals and wheat bran
Seeing this advice we can guess that most of cereal fibres intake by this group was from wheat although we cannot be sure.

This advice resulted on a 22% death increase:
Total mortality in the fibre advice groupFrom Stephan Guyenet
However this result bordered on statistical significance: the 95% confidence interval being 0.99–1.65.
For people not familiar with statistics, a result is usually defined as statistically significant when there is less than 5% chance that the result is due to luck alone. Here there is a 95% probability that the relative risk is between 0.99 (1% decreased chance of dying) and 1.67 (67% increased chance of dying).

Since the probability that the fibre advice resulted in a protective or neutral effect was a little too high, this result has been quite overlooked. Had the study last a little longer, it would have raised way more suspicion toward whole-grains.

In fact, researchers found this effect to be statistically significant in a follow-up study. After adjusting for pre-existing conditions and medication use, we can see in the table 4 of this study an hazard ratio of 1.35 (95% CI 1.02, 1.80) for the 2-year period of the randomized controlled trial.

These results are quite telling: according to these researchers, a 2 year randomized controlled trial showed that advising people recovering from an heart attack to eat at least six slices of wholemeal bread per day resulted in a statistically significant 35% percent chance increase of CHD compared to people not receiving this advice.

Wheat, Vitamin D Deficiency And Heart Disease

Many studies found that vitamin D deficiency is associated with CHD.
However vitamin D deficiency does not seem to cause heart disease. For example several studies found that vitamin D supplementation did not prevent heart disease.
As this study concludes:
A lower vitamin D status was possibly associated with higher risk of cardiovascular disease. As a whole, trials showed no statistically significant effect of vitamin D supplementation on cardiometabolic outcomes.
Wheat consumption causing CHD could help explaining these results. A study found that wheat consumption depletes vitamin D reserves. That could explain why vitamin D deficiency is associated with heart disease and why it does not seem to cause it: both vitamin D deficiency and heart disease could be consequences of wheat consumption.

Of course this is not the only explanation. For example the DART study shows that fish consumption prevents CHD and fish is a food rich in vitamin D.

Not the Perfect Culprit

To be clear, if it seems likely that wheat consumption is a risk factor of CHD it is not the only one nor the primary one. There are many other factors like smoking, hypertension, lack of exercice or stress. Even among dietary factors wheat is probably not the main one. For example the DART study shows that the protective effect of fish intake is stronger than the adverse effect of wheat.

In addition, deleterious wheat effects might not affect everybody. One study showed that the ApoB level variation following wheat and oat bran intake was different depending on the genotype of the individuals. In another study whole-wheat intake worsened the lipid profile only in people having a specific genotype compared to refined wheat.

How the wheat is cooked may have a role too. Studies show that sourdough bread improve mineral bioavailability (such as magnesium, iron, and zinc) compared to yeast bread or uncooked whole-wheat. Also content in proteins with potential adverse consequences like gluten or wheat germ agglutinin differs depending of the food type.

Conclusion

There are strong evidences that wheat consumption is a risk factor for CHD. People at risk of CHD should avoid wheat as should those trying to lose weight. In all cases, stopping wheat consumption for a month for example to see how one feel without wheat is always a good idea since there is currently no available method to diagnose non-celiac wheat sensitivities and that even for celiac disease the average delay in diagnostic is 11 years in the US.

More studies looking at the links between wheat and CHD are urgently needed since CHD is the leading cause of deaths while wheat is the second most widely consumed food and whole-wheat is often advised to lower risk of CHD. Studies considering grains as a whole are bound to give inconsistent results since different grains seem to have opposite effects in the case of CHD. So as much as possible future studies should treat grains separately and consider things like type of wheat products and genetic variability.

===============================================================
Read the complete article here or here.

Tuesday, November 12, 2013

Testosterone and the Heart Part Two - Dach

Testosterone and the Heart Part Two by Jeffrey Dach MD



In Part One, we discussed a 2010 study from Boston University in which testosterone was given to immobilized, elderly, obese male smokers.  The study was halted early because of poor outcome with increased heart attacks and “cardiac events”  in the testosterone treated group.

Second Study Shows  Poor Outcome in Testosterone Group

A second study from the University of Texas was just published in JAMA .(2)  This study was done on Veterans undergoing coronary angiography with documented coronary artery disease.  Some of these Veterans had low testosterone levels (below 300) .  These veterans were given testosterone treatment and followed.  At the end of three years of follow up, the untreated men had a  20%  incidence of stroke,  heart attack or death, while the testosterone treated group had a higher 26% incidence.  This is 20% untreated, vs. 26% treated.  Clearly, the testosterone did not miraculously reverse the atherosclerosis disease in this group of veterans.(2-6)

Benefits of Testosterone Clearly Documented in Medical Literature

As discussed in part one, decades of research studies have shown that low testosterone in men is a risk factor for early mortality from cardiovascular disease, and testosterone treatment reduces mortality, especially in the diabetic males. (7-10)

Testosterone Treatment Does Not Reverse Heart Disease

However, it is clear from these two studies that testosterone by itself is insufficient as a therapy to reverse coronary artery plaque in men who have diets and lifestyles which promote heart disease, and who already have significant underlying coronary artery disease.

Track Your Plaque BlogLeft Image logo courtesy of Track Your Plaque Blog.

Track Your Plaque Program

For our office patients who are interested in reversing coronary artery plaque, we use the William Davis MD Track Your Plaque Program. This is an excellent program which is well thought out.  See my article on this: Reversing Heart Disease.


I wonder what the outcome of these two studies would have been if the testosterone treated group had been started on the Track Your Plaque Program which monitors lipo-protein profile and the Calcium Score, and uses diet and lifestyle modification and supplements to reduce Calcium Score and increase LDL particle size.

There are many unanswered questions.  I also  wonder what the Vitamin D levels were, and what the thyroid levels were on these men,   How much trans fats were they consuming?  How much were they smoking and how much alcohol did they consume?  How much overweight were they?

Conclusion

One conclusion seems clear and that is testosterone by itself does not replace the Track Your Plaque Program of Diet, Lifestyle modification and Supplements to reverse heart disease.  As these two studies show, clinical outcomes for Testosterone Treatment may actually be worse for subgroups of men with severe coronary artery disease, especially when no changes are made to the diet and lifestyles that promote heart disease.

Jeffrey Dach MD
7450 Griffin Road, Suite 180/190
Davie, Florida 33314
954-792-4663
www.jeffreydach.com
www.drdach.com
www.naturalmedicine101.com
www.truemedmd.com

Articles With Related Content:

Low Testosterone Diagnosis and Treatment
HCG in Males with Low Testosterone
Testosterone Benefits, PSA and Prostate Part One
Testosterone and PSA Part Two
Clomid for Men with Low Testosterone Part One
Low Testosterone From Pain Pills
Low Testosterone Associated with Increased Mortality
Testosterone Reduces Mortality
Testosterone Blockade Increases Mortality
Testosterone Found Beneficial For Diabetes

Links and References:
(1)http://www.ncbi.nlm.nih.gov/pubmed/20592293
N Engl J Med. 2010 Jul 8;363(2):109-22. Epub 2010 Jun 30.
Adverse events associated with testosterone administration.
Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S. Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts 02118, USA.

2) http://jama.jamanetwork.com/article.aspx?articleID=1764051  Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels  by Rebecca Vigen, MD, MSCS1; Colin I. O’Donnell, MS2,3; Anna E. Barón, PhD2,3; Gary K. Grunwald, PhD2,3; Thomas M. Maddox, MD, MSc2,3,4; Steven M. Bradley, MD, MPH2,3,4; Al Barqawi, MD3; Glenn Woning, MD3; Margaret E. Wierman, MD2,3; Mary E. Plomondon, PhD2,3,4; John S. Rumsfeld, MD, PhD2,3,4; P. Michael Ho, MD, PhD2,3,4  The University of Texas at Southwestern Medical Center, Dallas 2VA Eastern Colorado Health Care
JAMA. 2013;310(17):1829-1836.

3) http://health.clevelandclinic.org/2013/11/concerns-raised-about-testosterone-therapy/  Concerns Raised about Testosterone Therapy Study: testosterone replacement linked to heart risks By Steven Nissen, MD | 11/8/13 2:26 p.m.
4) Testosterone treatments linked with heart riskshttp://www.thetowntalk.com/viewart/20131112/LIFESTYLE/311130006/Testosterone-treatments-linked-heart-risks
5) http://online.wsj.com/news/articles/SB10001424052702303661404579180294201174958  Testosterone Therapy Tied to Heart Risks
Veterans With History of Heart Disease Had Higher Risk of Death, Heart Attack and Stroke, According

6) http://www.latimes.com/science/sciencenow/la-sci-heart-disease-testosterone-replacement-20131105,0,3592717.story  Testosterone medication may boost risk of heart attack, stroke, death
7) http://www.ncbi.nlm.nih.gov/pubmed/22496507  J Clin Endocrinol Metab. 2012 Jun;97(6):2050-8. doi: 10.1210/jc.2011-2591. Epub 2012 Apr 11.  Testosterone treatment and mortality in men with low testosterone levels. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM.
Source  Veterans Affairs Puget Sound Health Care System, 1660 South Columbian Way, S-116PES, Seattle, Washington 98108, USA.

8) http://www.endocrine-abstracts.org/ea/0025/ea0025p163.htm
Endocrine Abstracts (2011) 25 P163
Low testosterone predicts increased mortality and testosterone replacement therapy improves survival in men with type 2 diabetes
Vakkat Muraleedharan1,2, Hazel Marsh1 & Hugh Jones1,2

9) http://www.ncbi.nlm.nih.gov/pubmed/23999642
Eur J Endocrinol. 2013 Oct 21;169(6):725-33. doi: 10.1530/EJE-13-0321. Print 2013.
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH.
Source  Robert Hague Centre for Diabetes and Endocrinology, Barnsley Hospital NHSFT, Gawber Road, Barnsley S75 2EP, UK.

Jeffrey Dach MD
7450 Griffin Road, Suite 180/190
Davie, Florida 33314
954-792-4663
www.jeffreydach.com
www.drdach.com
www.naturalmedicine101.com
www.truemedmd.com
=====================================================================
Read the complete article here.

Monday, October 7, 2013

Increased blood levels of Lp-PLA2 have been linked to increased risk for...

Lp-PLA2 (Lipoprotein-Associated Phospholipase A2)
  
Clinical Use
  • Assess risk of coronary heart disease and cardiovascular disease
  • Assess risk of stroke
Clinical Background
Traditional markers of lipidemia identify only about half of the individuals at risk of cardiovascular disease (CVD).1 Atherosclerosis is now recognized as an inflammatory disease, and inflammatory markers, most notably high-sensitivity C-reactive protein (hs-CRP), have been shown to identify additional individuals who are at risk. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is another marker of vascular inflammation, and because it is not associated with systemic inflammation it is more vascular-specific than is CRP.2 It is produced by macrophages and other inflammatory cells and is found in atherosclerotic lesions.
Increased blood levels of Lp-PLA2 have been linked to increased risk for: 1) cerebral thrombosis,3 2)
first4 and recurrent5 coronary events, 3) adverse prognosis after acute coronary syndrome,6 and 4) CVD associated with metabolic syndrome7 or type 2 diabetes mellitus.8 Evidence from more than 25 prospective studies has shown an approximate doubling of risk for coronary artery disease (CAD), CVD, and stroke when comparing Lp-PLA2 values in the top quintile versus the bottom quintile.2 The predictive value typically remains after adjustment for LDL-cholesterol and other established CVD risk factors.2
Thus, a consensus panel has recommended testing Lp-PLA2 as an adjunct to traditional risk factor assessment in individuals with moderate or high risk of CVD as defined by Framingham risk scores.9 According to the recommendation, an elevated Lp-PLA2 (ie, >200 ng/mL) suggests an individual’s risk is actually higher than that determined using Framingham risk scores, and more intensive therapy would be appropriate.9 For example, an individual with a moderate Framingham risk score and an elevated Lp-PLA2 may be reclassified as being at high risk, and the LDL-cholesterol goal would then be reduced from <130 dl.="" dl="" mg="" sup="" to="">9
The individual would also receive recommendations for more intensive life-style changes. Similarly, in individuals with an elevated Lp-PLA2 and high Framingham risk score, the LDL-cholesterol goal would be reduced from <100 dl.="" dl="" mg="" sup="" to="">9 Note that others have recommended a Lp-PLA2 cut point of 235 ng/mL, which coincides with the 50th percentile of the U.S. population, rather than the 200 ng/mL recommended by the consensus panel.10
The consensus panel further recommends use of Lp-PLA2 to refine risk for stroke.9
Screening with both Lp-PLA2 and hs-CRP may provide a better risk assessment for CVD and stroke than using either test alone. Elevated levels of Lp-PLA2 and hs-CRP were independent and complementary in identifying increased risk for future coronary events among healthy middle-aged men4 and patients with CVD.11
=====================================================
Read the complete article here.
 
Also listen to The Tuesday Talk Show where Dr William Blanchet discusses Lp-PLA2 here.

Monday, August 12, 2013

An incredible teaching opportunity on the basics of heart disease - Mandrola

The George W Bush stent case: An incredible teaching opportunity on the basics of heart disease


John Mandrola, MD August 11, 2013
 
The wrist artery hardly had time to seal. (Surely it was a radial.) The controversy came that fast.
The drumbeat of naysayers seemed to start only minutes after a prideful press release announced that George W Bush had undergone successful cardiac stent placement. The ever-quotable cardiologist from Cleveland Clinic, Dr. Steven Nissen, said, “This is really American medicine at its worst.” Dr. David L Brown, from Stony Brook University, and author of an important 2012 study on stents, added that GWB was “now the poster child for the inappropriate use of stenting.”

How could this be? It must be a good thing to uncover and treat heart problems before damage occurs. What do you mean he shouldn’t have had a blockage ‘fixed’ with a stent? Blockages are bad; let’s get them cleaned up. A clear artery is better than an obstructed one, right?

These common sense notions and the intense debate surrounding GWB’s stent offers us an incredible teaching moment for heart disease. It’s hard to believe our number one killer could be this misunderstood. But it is. Both doctors and patients struggle with the basics of atherosclerosis (hardening of the arteries).

This is big. Hidden in the nuances of the GWB case are important messages about the process of atherosclerosis and the significance of the vulnerable plaque. I believe advancing the knowledge of basic atherosclerosis would go far in correcting much of the over-treatment in cardiology today. The false expectations of screening stress tests and the surprise over the lack of benefit of stenting non-symptomatic disease illustrates the wide swath of misinformation out there.

My aim is to use this controversy to spread the facts and fundamentals about atherosclerosis and heart disease.

Consider this question as you read: If you had the choice between two types of blockages in one of the three main coronary arteries (the arteries that supply the heart), which would you choose: Choice A is a thick smooth 80% blockage. Choice B is a thin-walled 10% blockage.
The GWB story:
A former president of the United States gets careful medical attention. In the course of this quite careful care, a significant coronary blockage was discovered. Like many patients with heart disease, Mr. Bush had no symptoms. He did not report chest pain, shortness of breath or dizziness. He is known to be an avid cyclist, a mountain biker even. I don’t know the former president, but I know mountain bikers. He likely demanded a lot from his heart at times. GWB is also special in that it’s hard to quantify the inflammation of 8-years in the White House. (You writers know how much criticism inflames; imagine half the free world thinking badly of you.)

The controversy in this case centers on two issues: First, why did a non-symptomatic patient get an exercise study in the first place? Second, why was a stent used to treat a blockage that was not causing symptoms?

Lack of benefit for stents in stable coronary artery disease:
Let’s begin with the second issue and work backwards. To understand the stent debate, we need to start with the aptly named COURAGE trial, published in 2007 in the New England Journal of Medicine. Researchers screened many thousands of patients to come up with about 2300 study subjects with significant coronary artery disease–similar to the former president’s. COURAGE studied two treatment strategies: about 1100 patients were randomized to optimal medical therapy and another 1100 had optimal medical therapy plus a stent placed in any blockage greater than 70%. Researchers made sure both groups had intense medical therapy, including regularly scheduled nurse-managed visits, free medicines, and dietary and exercise counseling. They then followed patients for five years and compared hard outcomes. COURAGE got its acronym because it was felt courageous to leave patients with major blockages on medicine alone. Prevailing wisdom held that major blockages needed to be stented. (But you know how prevailing wisdom often turns out.)

COURAGE investigators showed that adding a stent to optimal medical therapy and lifestyle changes made no difference in the risk of death, heart attack or stroke. Criticism of COURAGE was robust. The trial enrolled mostly white male patients and bare metal (not drug-eluting) stents were used. Some said the intensity of medical therapy was unrealistic in the real world. (A highly relevant criticism in this era of lean healthcare delivery.) Applicability of COURAGE was also called into question as the investigators had to screen many thousands of patients to get down to 2300 subjects.
These findings, however, turned out to be no fluke. In 2012, a meta-analyses of 8 similar stent trials (JAMA –IM), including 7229 patients, confirmed the lack of benefit for stents in patients with stable coronary artery disease.

It was settled then; stents should only be used in symptomatic patients, like those having heart attacks, chest pain, arrhythmia, or in those with weak hearts and congestive heart failure. Using stents pre-emptively did not work to prevent heart attacks, strokes or death. For the record, when angioplasty (the precursor of stents) was used in asymptomatic patients, it did not prevent heart attack, stroke or death either.

The explanation: Consider basic atherosclerosis.
Coronary artery disease stems from diffuse disease of the blood vessel wall. (We call the inner lining of the blood vessel the endothelium.) Wrong thinking holds that blood vessels are inert pipes that carry blood to organs. So, if a blockage exists, squish it open and voila, it’s fixed. This is total nonsense. The blood vessel wall, the blood itself, and their interaction are wildly active in a biologic sense. (I hate the word dynamic, so let’s just say the endothelial-blood interface is far from static.) Sticky platelets, irritable endothelium, the two together–this is heart disease.

Think of the things that can happen in a blood vessel: One possibility is that overtime a slow-growing thick-walled plaque accumulates cholesterol and fat. The growth may enlarge enough to obstruct blood flow to the heart (or any organ). These ‘stable’ blockages can cause angina—a short supply of nutrients at times of high demand. Though impressive to look at, because of the degree of obstruction, these plaques are less of a problem. We say they are less vulnerable to rupture. What’s more, not only are these thick stable plaques unlikely to rupture, but the downstream heart muscle gets accustomed to periods of low nutrients–ischemia. We say that part of the heart is pre-conditioned for ischemia. (I’ll come back to that.)

Another (more worrisome) thing that happens in blood vessels can occur in the earlier phases of heart disease. It’s these younger, less developed, more thin-walled and non-obstructive plaques that cause heart attacks, strokes and sudden death. These are the vulnerable plaques. Because vulnerable plaques don’t obstruct blood flow and rarely have calcium in them, they are neither symptomatic nor detectable by stress testing, coronary CT or heart catheterization. Innocuously termed “lumen irregularities,” these areas of disease are where the danger lies. Here’s why: the thin-walled plaque is more likely to fissure. A tiny crack exposes the inside of the plaque to components of the blood. What happens to your skin when you cut it? It bleeds, and then a clot forms. That’s okay on you arm, but clot formation in the inside of a blood vessel leads to abrupt occlusion of the vessel—a heart attack or stroke. And sudden death due to arrhythmia can occur in this scenario because the supplied heart muscle is not used to low nutrient levels. Non-pre-conditioned heart muscle is electrically irritable. Plaque rupture is why people can die suddenly the day after a normal stress test.
And there’s more. Non-obstructive, possibly vulnerable, plaques occur throughout the three major coronary arteries. Yes, there may be one bad 80% blockage, an eyesore that captures the attention of the cardiologist, but when there is one bad blockage, there are often many other much more vulnerable plaques. So the problem with the major blockage is not just the restriction of downstream blood flow, but rather, it’s a marker for diffuse atherosclerosis. That’s one reason why stents don’t prevent heart attacks or death. The stent treats the blockage least likely to cause the calamity.
But that’s not the only problem with stents. Another issue is that stents create their own disease. The metal cage inside a blood vessel can act as a source of clots. This means patients with stents must take drugs that block platelet function. These “blood thinners” increase the risk of bleeding. The duration of anti-platelet treatment varies depending on patient and stent characteristics, but is often long-term. Stopping an anti-platelet drug shortly after a stent, say in the event of trauma or surgery, greatly increases the risk of abrupt stent closure and heart attack. So stents aren’t free; they come with significant long-term tradeoffs.

The role of Inflammation:
Coronary artery disease equals atherosclerosis. It is a diffuse process involving inflammation in the blood vessel wall. The things that cause atherosclerosis are well-known, and work through chronic inflammation. Smoking is especially terrible. It causes long-term plaque accumulation, increases in platelet stickiness and irritation of the blood vessel wall. Smoking cessation results in near immediate decreases in vulnerable plaque rupture. It’s why you see so many fewer heart attacks with smoking bans; removing exposure from smoke has an immediately soothing effect on blood vessels. High blood pressure exerts its effects on the blood vessel via physics. Imagine 100,000 daily pulses of blood through a soft flexible blood vessel versus a stiff non-complaint hypertensive one. Stiff pipes are more apt to crack. Diabetes wreaks havoc in many ways. Insulin is a real baddie for blood vessels. As a growth factor, insulin causes deposition of fat in plaques. As an inflammation mediator, insulin contributes to the irritability of plaques. You don’t want high insulin levels; this is why a low-calorie diet devoid of simple sugars is so effective. Ask the healthy 90 year-old farmer from Indiana, how much food from packages he eats. Stress takes a toll over time as well. We know chronic angst, unhappiness and anger all associate with heart disease. The common denominator here is also inflammation. When you are inflamed emotionally, so are your platelets and endothelium. Genetics plays a strong role too. We inherit eye color, personality, intelligence, aerobic prowess and so on. We also inherit susceptibility to arterial disease.

I hope you can see why treating and preventing heart disease is not just about squishing low-vulnerability plaques. You can understand why the COURAGE trial showed that adding stents to optimal medical therapy did not lower the risk of heart attack or death. And, if the plaques most likely to kill are not obstructive, you can also understand the limits of stress testing.

Effective treatment of heart disease:
Although we are not close to knowing which of the many thin-walled 10% coronary plaques are vulnerable, we still have a lot that we can do. Note the pronoun, we.
stat
Heart disease therapy means addressing a diffuse disease. It means reducing both the number of plaques and their vulnerability. Ultimately, this is about lowering inflammation. First comes lifestyle. Remember the four legs of the table of health: good food, good exercise, good sleep and good attitudes. Eating less insulin-spiking sugar, inflammatory trans-fats and fewer calories lowers inflammation. The emerging understanding of the importance of gut bacteria gives credence to the saying, we are what we eat. Nutrition is not complicated: eat real food when you are hungry. Exercising every day that you eat soothes the mind, conditions the heart and keeps the body from accumulating fat. Our bodies are beautiful; it’s tragic when humans don’t use their bodies. Getting high quality sleep lowers inflammation. You don’t need me to tell you how good it feels to sleep well. Finally, I’d bet every bike I own that compassion, grace and optimism soothe the vulnerable plaque.

After lifestyle comes medical therapy. Statin drugs don’t prevent heart attacks, strokes and death by lowering cholesterol; that’s just something us humans can easily measure. Statin drugs improve outcomes in patients with established heart disease by reducing inflammation at the arterial wall/blood interface. Beta-blockers and ACE-inhibitors (and ARBs) aren’t just simple blood pressure lowering agents. They have important activity on the neuro-hormonal milieu of the diseased heart and blood vessel. And simple aspirin therapy goes a long way in preventing platelets from accumulating on vulnerable plaques. Science confirms that these classes of drugs lower event rates in patients with established heart disease or those at high-risk of heart disease. I call them the big four heart medications. (BTW: they are all generic!)

Heart disease treatment, however, remains a team sport. Doctors can’t do it alone. Right now, there’s far too much emphasis on treating a diffuse disease with focal therapies. Stents may improve blood flow; bypass surgery may provide a brief reprieve; ICDs offer some protection to selected patients, but it will always be about lowering inflammation. There’s no pill or stent or ICD for that.

JMM
===============================================================
Read the complete article here.

Thursday, May 16, 2013

“Carnitine Causes Heart Disease” - Colpo

As Usual, an excellent read from none other than Anthony Colpo, independent researcher, physical conditioning specialist, and author. His wit, wisdom, and ability to analyse tomfoolery in topics re diet and medical that otherwise seem scientifically sound make this article required in my opinion. And while I do not really like some of his choice of words, I choose not to be offended. So here it is - Read it and smile and enjoy the unabashed logic Anthony brings.
===================================================================
Bullshit Study of the Year: “Carnitine Causes Heart Disease”

Warning: This article contains language some folks would consider naughty. If you are deeply offended by words that start with “Sh…” and rhyme with “git”, you should close this page immediately and go back to reading Better Homes and Gardens.
If ever you needed proof the world is heavily populated by utter morons, all you’d need to do is examine a recent study appearing in Nature Medicine, wonder how supposedly educated people could ever contrive such utter rubbish, then marvel at the ease with which this pseudoscientific slop has been uncritically soaked up by media outlets and individuals all around the world.

I’m talking, of course, about the current “Carnitine in Red Meat Causes Heart Disease!” nonsense doing the rounds in the mainstream media, that preeminent source of misinformation that plays a key role in keeping the general population as dumbed down, confused and distracted as possible.
The Plain Facts, Whether You Like Them or Not

Before I begin tearing apart this joke of a ‘study’, I want to make a couple of things perfectly clear:
 
–Carnitine does NOT cause heart disease.

–No-one -I repeat NO-ONE – has ever shown red meat nor supplemental carnitine to cause heart disease in human beings. Not the ‘researchers’ responsible for the appalling Nature Medicine paper, and not anyone else.
So what’s with this latest study? Where do the researchers get off making such idiotic claims?

carnitine-NOW

If you earnestly believe this stuff causes heart disease, my condolences. Life must be tough without a brain.


How to Make Headlines With Complete and Utter Garbage in 3 Easy Steps

The only kind of study equipped to support a fantasmagorical claim like “Carnitine Causes Heart Disease!” is a randomized controlled trial (RCT) in which you take a bunch of volunteers, randomly assign them to two groups, then assign one group to take carnitine supplements and the other a placebo. You would then let the study run long enough for people to start dying from heart disease (if the participants had preexisting CVD, this will generally happen a lot sooner). After several years (or less if one group showed a huge advantage over the other, in which case you would be ethically obliged to end the trial early) you would tally up the data.

By the way, if this trial was intended to examine the effects of carnitine on CVD incidence and mortality in human beings – as opposed to rats, mice, pigs, or Mongolian Gerbils – then it must meet another absolutely essential requirement: The participants of the trial must be human beings.
“No shit Anthony!“, you say? Hey, you’d be amazed at how many highly-decorated researchers apparently can’t tell the fundamental differences between a rodent and an adult Homo sapien. And that includes the authors of the Nature Medicine paper, as we’ll discuss shortly.

If the data from your human RCT showed more people in the carnitine group died of heart disease and your trial was a meticulously conducted endeavour pretty much free of confounding factors, dodgey researcher behaviour, or untoward influence from parties with a vested financial interest in the results, then and only then could you justify the claim “Carnitine Causes Heart Disease!” Even then, for the finding to be accepted as gospel fact by the scientific community at large, your research would need to be replicated and validated by other researchers.

So conducting such a carefully controlled trial must be what the Nature Medicine paper authors did, right? After all, they sound pretty damn confident that “Carnitine Causes Heart Disease!”
They did nothing of the sort.

Instead, they engaged in an exercise known as PIM (Pseudoscientific Intellectual Masturbation).
To be a good PIM-artist really isn’t that difficult. All you need, along with seemingly impressive credentials, is to serve up the right mix of shady inferences, dodgey extrapolations and ridiculous but tantalizingly sensationalist conclusions. Write a good press release, and you can be assured the shocking ignorance of most health reporters and the public’s eternal gullibility and faith in authority will do the rest.

The title of the paper, which Nature Medicine posted on its website on April 7 ahead of print, is Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Again, we can see the authors aren’t mincing their words – as far as they’re concerned, they’ve conclusively established a causal role for carnitine in the pathogensis of heart disease.
In their dreams, baby.

Why This Study is a Load of Bollocks

The very first line of the study’s text reads:

“The high level of meat consumption in the developed world is linked to CVD risk, presumably owing to the large content of saturated fats and cholesterol in meat1,2. However, a recent meta-analysis of prospective cohort studies showed no association between dietary saturated fat intake and CVD, prompting the suggestion that other environmental exposures linked to increased meat consumption are responsible3.”

See the numbers “1″, “2″ and “3″ at the end of the first and second sentences? These are citation numbers referring to the studies allegedly confirming what those sentences are saying. So let’s take a look at these studies.

Sudy “1″ can be found here. It was the Nurses’ Health Study and, yes, the researchers claimed that red meat intake was associated with a higher risk of CVD and diabetes. This was not an RCT but an epidemiological study, which means it was a load of uncontrolled, confounder-prone slop. As I have explained many times before, epidemiological studies are hopelessly subject to innumerable confounding factors over which the researchers have absolutely no control (and don’t give me this bollocks about “multivariate analyses”, which is simply an abbreviated way of saying “sophisticated mathematical chicanery that convinces epidemiologists they have god-like powers and can endow their work the same kind of robust validity seen with carefully conducted RCTs”).

So what I want you all to do now is open the PDF for the NHS paper and scroll down to pages 11 and 12 to view Table 1, which contains the baseline characteristics of the participants (to avoid contorting your neck, right click on the table and select “Rotate Clockwise”). Remember what I said about these garbage epidemiological studies being hopelessly prone to confounders? The NHS is a textbook classic example – we can clearly see that as red meat consumption went up, so too did smoking rates, trans fat intake, and history of angina/diabetes/blood pressure. And as red meat intake increased, levels of physical activity decreased.

In other words, subjects in the higher red meat quintiles clearly lived unhealthier lives and possessed several other unhealthy traits totally unrelated to red meat intake.

Here’s a few facts for our red meat-hating brethren in the epidemiology community to ponder:

–The primary source of trans fats are refined vegetable fats (you know, the same fats our idiotic health authorities told us were “heart healthy”, then quietly backed away from when mounting evidence showed otherwise).

–Smoking, meanwhile, involves ingestion of noxious gases from nicotine-containing products, primarily cigarettes. In my four-plus decades on this crazy blue ball called Earth, I’ve yet to see someone roll a topside steak, light it up, and draw on it like a Marlboro. In other words, red meat has nothing to do with smoking, and to blame the effects of the latter on the former is sheer idiocy.

–Any claim that red meat intake causes physical inactivity is similarly absurd. In fact, given its high concentrations of B-vitamins, creatine, iron, and carnitine (critical for energy production, idiotic statements about CHD from clueless researchers notwithstanding), we would reasonably expect red meat intake to facilitate, rather than impede, strenuous exercise.

–There is no reliable evidence whatsoever to support any notion that angina, diabetes and high blood pressure are caused by red meat intake. They are, however, promoted by smoking, inactivity, and trans fat intake, all of which increased among the NHS subjects along with rising red meat intakes. These ailments are also strongly linked to such factors as high refined carbohydrate intakes, stress, ambient pollution, and high bodily iron stores – none of which were reported in Table 1.

So yes, in the NHS, red meat was indeed “associated” with higher rates of CHD, but in the same way a woman who unwittingly marries a serial killer is “associated” with violent crime. The latter is not responsible for her husband’s murderous behaviour, and the former is in no way responsible for the otherwise unhealthy behaviour of its most voracious consumers.

So why would people who consume more red meat exhibit generally unhealthier lifestyle and dietary habits?

It’s simple. People who care less about their health, and ignore exhortations to avoid trans fats/smoking/inactivity are also more likely to ignore recommendations to avoid or limit red meat consumption. And so red meat is eaten in higher amounts among these subjects, allowing dodgey epidemiologists who think health research is all about clever statistical shenanigans to create “associations” between red meat and all sorts of health ailments. They then pronounce these associations as causal rather than statistical, blatantly ignoring one of the most fundamental rules of good science:

ASSOCIATION DOES NOT EQUAL CAUSATION.

Health-conscious people, by the way, will also be more likely to eat poultry compared to red meat, which is why this source of animal flesh was associated with a lower risk of CVD in the NHS.
There’s one more thing I’d like to point out about the NHS paper. If you look at the “Body Mass Index” scores among the various quintiles of red meat consumption, they are pretty much identical. But scroll down to the “Calories” data, and you’ll see that as red meat intake increases, so too does the self-reported calorie intake. So what we are supposed to believe from this hogwash is that people who eat less red meat maintain the same level of overweight as people who eat higher amounts, despite eating 700 less calories per day!

You’d have to be Gary Taubes to believe bullshit like that.

So if the self-reported calorie intakes are way off the mark, what else in the NHS data is wildly inaccurate? Who knows. Like I said, it’s just a mass of totally uncontrolled, dubiously reported (a single dietary questionnaire every four years) and hopelessly confounder-prone data, ripe for dredging and misinterpretation by those happy to accept weak statistical odds ratios as physiological fact.

Anyway, let’s leave the bad joke that is the NHS red meat paper and move onto reference “2″. Before I discuss this paper, I want to reiterate that the Nature Medicine paper authors cite it in support of their claim “high level of meat consumption in the developed world is linked to CVD risk“.

The reality is it showed nothing of the sort, as you can see for yourself by clicking here. This paper was a meta-analysis examining the pooled data from not one, not two, but 20 epidemiological studies dealing with red meat and CVD and/or diabetes risk. Yessirree, a genuine all-you-can-eat epidemiological extravaganza encompassing data for some 1,218,380 individuals and 23,889 CHD, 2280 stroke, and 10,797 diabetes cases.

And what did it find? “Red meat intake was not associated with CHD…or diabetes mellitus”. Nor was it associated with stroke.

Processed meat intake was associated with a 1.42 and 1.19 increased risk of CHD and diabetes, respectively, but not stroke. Whether this is because of an unhealthy consumer phenomenon similar to the one we saw for red meat in the NHS, or a genuine detrimental effect of processed meat, or whether we should just ignore the results period because 1.42 and especially 1.19 are pathetically weak hazard scores considering the confounder-prone source, is an entirely different discussion. What matters here is that, despite the massive data-dredging opportunity it presented, the most massive analysis to date found no relationship between red meat and heart disease.

But the Nature Medicine authors cite it as showing that red meat is associated with CHD. Why would they say this when it is patently untrue? The NM paper has 23 listed contributors from a mix of institutions including Cleveland Clinic, University of California–Los Angeles, Cleveland State University, Perelman School of Medicine at the University of Pennsylvania, Wake Forest School of Medicine in North Carolina, Children’s Hospital Oakland Research Institute in Oakland, California.

Are we to seriously believe none of these 23 researchers read the meta-analysis in its entirety?

Are we to seriously believe none of them saw the words “Red meat intake was not associated with CHD“?

So why have they cited the meta-analysis in support of a statement patently at odds with its findings?

It gets worse.

Study “3″ can be found here. This study did not deal specifically with red meat intake; rather, it examined the relationship between CVD and saturated fats in general (i.e. not just from red meat, but other meats, dairy products, etc). This was also a meta-analysis, incorporating epidemiological data for 347,747 subjects, 11,006 of whom developed CHD or stroke. Contrary to decades of dedicated anti-saturate brainwashing, there was no relationship between saturated fat intake and CHD, stroke or CVD risk.

Now, I need you to re-read the first 2 sentences of the Nature Medicine paper – c’mon, humour me, it’s important:

“The high level of meat consumption in the developed world is linked to CVD risk, presumably owing to the large content of saturated fats and cholesterol in meat1,2. However, a recent meta-analysis of prospective cohort studies showed no association between dietary saturated fat intake and CVD, prompting the suggestion that other environmental exposures linked to increased meat consumption are responsible3.”

Did you notice the subtle but very dodgey sleight of hand performed by our anti-carnitine crew? The first sentence claims an association between meat intake and cardiovascular disease, but the second sentence claims this relationship is not explained by saturated fat intake. Despite having red meat squarely in their sights, they’ve also carefully slotted the word “meat” into the sentences rather than “red meat”, so they can technically claim study “2″ in support, even though it only found an association for processed meat (red meat by far is the richest source of carnitine; the carnitine content of processed meat varies widely due to its use of various meats, fillers and often high fat content; white meat contains negligible amounts).

So the reality is one of the studies allegedly showing a relationship between red meat intake and CVD was hopelessly confounded by other unrelated factors, while the much larger and all-encompassing meta-analysis showed no relationship of red meat – irrespective of its saturated fat content – with CVD. Yet the authors falsely claim otherwise, then lead into the saturated fat argument to pave the way for their carnitine hypothesis.

In other words, their carnitine hypothesis is based on a false premise. They go on to claim that carnitine may be the real explanation for the relationship between red meat and CVD, but there is no relationship between red meat and CVD!

So the underlying assumption upon which they build their carnitine theory is utter rubbish. I’m sure you guys don’t need me to remind you what happens to elaborate structures built on quicksand…

Up, Up and Away With TMA
Not to be deterred by the small matter of their thesis being built on a blatant falsehood, the Cleveland Clinic-led researchers then go searching for an alternative culprit to explain their mystical relationship between red meat and CVD.

They settle on a rather unusual choice, a substance known as trimethylamine, or TMA for short.
What the bleep is trimethylamine, I can hear you all asking?

Trimethylamine belongs to a group of organic compounds known as amines, and has a pungent, fishy, ammonia-like odor. TMA is formed naturally during the decomposition of plants, fish and animal products, and is ingested in foods such as fish, or from foods containing TMA precursors such as trimethylamine oxide (TMAO), choline, and L-carnitine, which are metabolized to TMA by enterobacteria.

TMA is the substance mainly responsible for the funky smell imparted by rotting fish. It is present in the plasma and urine of humans, and can also contribute to the less-than-pleasant aromas arising from some infections, bad breath and vaginal odors.

Sounds pretty gross, but TMA is present in every one of us after we eat foods containing TMA precursors. Conversion back to TMAO is the major fate of most TMA in our bodies, and considerable variability exists among humans in the efficiency of this process.

In a nutshell, what the authors of the Nature Medicine paper are saying is that when we eat red meat, the carnitine in that meat gets converted to TMA by microbes in our gut. That much is straightforward, concurs with what we already know about carnitine and TMA, and pretty much falls into the category of “Um, yeah, so what?”

It’s what the authors claim next that strains the boundaries of credulity. They claim that this newly formed TMA goes on to cause heart disease by promoting uptake of cholesterol into the artery walls.
For crying out loud…

CHOLESTEROL DOES NOT CAUSE HEART DISEASE.

The evidence absolving cholesterol of any causative role in atherosclerosis from heart disease is so abundant I was able to fill an entire book with it. And the best that any of my critics have been able to muster in response is to accuse me of being a money-hungry profiteer who resides out in left field (hi Dr Gholke, Pee Pee, Janet, et al!) In other words, they cannot even begin to factually refute the points I raise in the book.

Here are the facts:

–The campaign against saturated fats and cholesterol was born in 1953 after a shameless researcher by the name of Ancel Keys plotted the total fat intake and CHD mortality for six countries on a graph. By doing so, he was able to show a strong linear positive association between the two; as fat intake went up, so too did CHD mortality. But what he didn’t mention in his paper was that data for twenty-two countries was available at the time, and he’d simply chosen the six countries that best supported his thesis and flippantly ignored the rest. Depending on which six countries Keys chose, he could have shown fat intake was completely unrelated to CHD mortality, or he could even have shown that as fat intake went up, CHD mortality went down. Key’s research was patently fraudulent, but his driven, domineering manner and his position on the American Heart Association’s nutrition advisory panel saw to it that his shambolic findings eventually became official public policy. The anti-fat theory promptly morphed into the anti-cholesterol theory, and initially saw the heavy promotion of polyunsaturated fats as ‘healthier’ substitutes for saturated fats.

The above is now common knowledge, so why do so many researchers and health authorities keep up with the anti-cholesterol sham when from the very outset it was based on a fraud?

–Autopsy studies have repeatedly shown no relationship between blood cholesterol levels and atherosclerosis. Some of these studies observed recently deceased people with very low cholesterol levels but severely atherosclerotic arteries.

–Decades of dietary intervention trials have completely failed to lower coronary mortality, despite the fact that blood cholesterol levels were indeed lowered in the intervention groups.

–The most successful dietary intervention trial ever conducted, the Lyon Diet Heart Study, slashed mortality rates among those assigned to an omega-3, antioxidant-rich “Mediterranean” diet, even though cholesterol levels between the diet and control groups remained identical throughout the study.

–Statin drugs, those overhyped and inherently toxic agents that nonetheless have shown CHD mortality reductions in some population groups, only work because they possess a whole host of effects aside from mere cholesterol-lowering. This is why they’ve been able to deliver meager mortality reductions where their predecessors, the fibrates, were able to deliver none. In one particularly telling study- which, ironically, was published in Nature Medicine – researchers took the popular lovastatin and completely disabled its cholesterol-lowering abilities, then found it still possessed potent anti-inflammatory effects.

These are just a few of the contradictions to the untenable cholesterol hypothesis of heart disease that I discuss in The Great Cholesterol Con (you know, the book I allegedly wrote while residing out in “left field” and has since apparently made me millions of dollars, which of course is why I’m sitting here on a Saturday morning writing this article when I’d much rather be sipping Frangelico in the Caribbean or doing my darndest to destroy the gearbox on a brand new Lamborghini*).

I also debunked the “LDL Cholesterol is Bad Cholesterol!” bollockery in a Journal of American Physicians article that you can freely access here (for a Spanish version, click here).

I will repeat: Cholesterol does not cause heart disease. Cholesterol is an essential component of your cell membranes, and if someone were to suck all of the cholesterol out of your body you’d promptly collapse on the floor into a pile of mush, hair and bones.

Because of its key role in providing structural integrity to cell membranes, cholesterol constitutes an important repair substrate for our bodies. The lipid hypothesists wank on and on about how atherosclerotic plaques have been observed to contain cholesterol, but big deal. They’ve also been observed to contain white blood cells, calcium, the allegedly heart-healthy omega-6 fatty acid linoleic acid, fibrous tissue, and more. Now, if someone came along and said we should all go on diets or take drugs that lower our white blood cell count in order to fight heart disease, they’d be roundly ridiculed and laughed at. Ditto if they said we should eat diets or take drugs that destroy fibrous tissue or deplete our body of calcium. But when someone comes along and makes the equally ridiculous claim that we should eat Spartan diets and take powerful drugs in order to lower our blood cholesterol, they make the cover of Time magazine, receive awards for their monumental contribution to furthering human ignorance cardiovascular science, take up lucrative positions at “lipid clinics” where they can further research the non-existent relationship between cholesterol and CHD while the rest of us work real jobs, and receive lucrative honoraria from drug companies to boot!

I just love the way this shit works. Not.

The bottom line is that cholesterol, just like most other components of atherosclerotic plaque, is in the plaque as part of the body’s attempt to repair a damaged section of artery. Cholesterol does not cause heart disease, no more than police officers and paramedics cause the accident scenes they attend – they’re there to deal with the mess after the accident already happened.

Cholesterol’s importance in the repair process may be a key reason why heart attack patients presenting to the emergency ward suffering heart attack and displaying high cholesterol levels are far more likely to survive the ordeal than those presenting with low cholesterol levels. Yeah, I know, you probably never heard this and it goes against all your anti-cholesterol brainwashing, but it’s true[1-4].
So as it turns out, the Nature Medicine anti-meat/anti-carnitine paper is now based on two utterly false premises. In addition to the “meat causes heart disease” fantasy, the researchers have also added the fairy tale about cholesterol causing heart disease to their repertoire of dodgey working assumptions.

Guys, can I stop here? Seriously, the idiocy is killing me!

Huh? What’s that? You want me to keep going? Something about never leaving a job half-done? And you want to hear more about this TMA charade?

Ah, bugger. Alright, on we go…

TMA = Too Many Assumptions [of a Most Untenable Nature]
Okay, so we’re now up to the bit where the researchers fed some volunteers carnitine supplements as part of their TMA gig. Before I describe what happened, I just have to share the following passage from p.2 of their paper with you:

“Given the similarity in structure between l-carnitine and choline (Fig. 1a), we hypothesized that dietary l-carnitine in humans, like choline and phosphatidylcholine, might be metabolized to produce TMA and TMAO in a gut microbiota–dependent fashion and be associated with atherosclerosis risk. To test this hypothesis, we initially examined data from our recently published unbiased small-molecule metabolomics analyses of plasma analytes and CVD risks.

An analyte with identical molecular weight and retention time to l-carnitine was not in the top tier of analytes that met the stringent P value cutoff for association with CVD. However, a hypothesis-driven examination of the data using less stringent criteria (no adjustment for multiple testing) revealed an analyte with the appropriate molecular weight and retention time for l-carnitine that was associated with cardiovascular event risk (P = 0.04).”

Due to the heavy use of gobbledegook, many of you won’t have a clue what all that means, but those of you familiar with both science-speak and the dodgey behaviour of statisticians are no doubt smiling one of those deep, knowing smiles right now. What they are essentially saying, in plain English, is this:

“We came up with this bright idea that carnitine might be converted to TMA and that this might increase CVD risk. So to see if this had any validity, we pulled out the data from a recent analysis we did linking itty bitty chemical substances to CVD risk. As it turns out, there were no substances with the same key characteristics as l-carnitine that were associated with CVD risk, which effectively sent our thesis down the toilet.

Damn.

However, we weren’t going to give up that easily, because if we could somehow support our thesis it could get us some kick-ass coverage in the media! Hey, nothing like another headline-grabbing paper to keep those research funds flowing in!

So what we then did was pretty much the research equivalent of donning beer goggles in order to make an ugly woman attractive enough to sleep with: We dramatically loosened up our criteria until we finally found a substance that had similar characteristics to l-carnitine and delivered us the statistically significant association we needed to proceed with our charade. Gotta love statistics! With enough TLC, you can massage and bend those numbers any way you want, baby!”

So after gettin’ jiggy with the “metabolomic” data and finding the flabby, dateless, gap-toothed association they were after – not with carnitine mind you, but with a substance that kinda sorta was a little bit like carnitine – they then proceeded with the clinical phase of their caper.

To get this phase rolling, they fed five omnivorous subjects an 8-ounce sirloin steak, corresponding to an estimated 180 mg of l-carnitine, together with a capsule containing 250 mg of isotope–labeled l-carnitine. They then observed modest post-meal increases in carnitine and TMAO.

Then, to examine the role of gut microbes in TMAO formation from dietary l-carnitine, they placed the same volunteers on oral broad-spectrum antibiotics to suppress intestinal microbiota and then performed a second l-carnitine “challenge”. After the week-long treatment with the antibiotics, they noted near complete suppression of detectable TMAO in the subjects’ blood and urine.

Nothing outlandish there.

Then they rounded up some more omnivores and also found themselves a bunch of vegans and vegetarians. They found fasting baseline TMAO levels were significantly lower among the vegans and vegetarians. In a subset of these individuals, they performed another carnitine challenge (but with no steak, only supplements) and found the vegans and vegetarians had a markedly reduced capacity to synthesize TMAO from the supplemental carnitine. Vegans and vegetarians also had significantly higher post-challenge plasma concentrations of carnitine compared to the omnivores, indicating they were unable to metabolize the carnitine as effectively. Given that carnitine plays a key role in cellular energy production, this is hardly worth bragging about, but as you’ll soon learn the researchers carry on like this is in fact a wonderful thing.

The next sections of the paper deal with the researchers fishing through some of the subjects’ faeces to determine the concentrations of choline, carnitine, TMAO and gut bacteria. This task, which I’m guessing they assigned to the junior members of the team, found certain types of bacteria were associated with plasma TMAO levels and being omnivorous or vegetarian/vegan. This in turn suggests that your usual diet will have an effect on both the bacterial composition of your gut and your ability to synthesize TMA and TMAO from dietary l-carnitine.

Again, nothing particularly outlandish.

Return of the Bollocks
It doesn’t take long, however, for things to start going downhill again. After some mice experiments which I’ll discuss later, the researchers put their epidemiological costumes back on and examined the relationship of fasting plasma concentrations of l-carnitine with CVD risk in 2,595 subjects undergoing elective cardiac evaluation. Among this sample, they observed a positive association with plasma carnitine and coronary artery disease, peripheral artery disease and overall CVD.

A look at the supplementary data soon reveals why: As plasma carnitine levels rose, so too did the patients’ age, rate of smoking, and pre-existing CAD and CVD. Yessir, the same old unhealthy-lifestyle-meets-red-meat phenomenon that has confounded so many other epidemiological studies is again at work here.

What a joke.

After the usual overrated adjustment for a limited range of “traditional CVD risk factors”, only the highest quartile of plasma carnitine showed an increased ‘risk’ of any note.

From this terribly slanted epidemiological study, they also examined the relationship between plasma carnitine and 3-year risk for composite of adverse cardiac events (death, myocardial infarction, stroke and revascularization). Again, only the highest quartile of carnitine concentration was associated with this composite endpoint, after adjustments for several CVD risk factors.

After further adjustment for plasma TMAO concentration and a larger number of accompanying comorbidities (e.g. extent of CAD, ejection fraction, medications and estimated renal function), the significant relationship between carnitine and the composite endpoint was completely abolished. For example, in patients exhibiting high plasma carnitine but low TMAO, the relative risk was actually reduced (0.80 adjusted hazard ratio) when compared to patients with low levels of both.
I guess that kinda got left out of the press release…

In patients with high levels of carnitine and TMAO, the HR was 2.1. But what does that prove? Absolutely nothing, except that high levels of carnitine and TMAO were associated with a higher risk of composite CVD endpoints in a sample of 3,000 patients. Exactly why they were associated with higher risk is anyone’s guess; Was it causal or, as per the situation with cholesterol, an after-the-fact association? This study is simply not equipped to tell us that, although I am here to tell you without a shadow of a doubt that carnitine does not cause heart disease. I’ll present the evidence for that assertion in uno momento, but for now let’s look at the next section of the study.

More Mouseshit
After the epidemiological entree, the researchers serve up their main course. Yep, this is where they roll out the mice and feed them either their usual chow diet or the same fare plus supplemental l-carnitine. The mice fed carnitine, of course, go on to develop more ‘atherosclerosis’ than those fed standard chow. I say “of course” because it hardly takes a brain surgeon to figure what is going to happen when researchers showing strong signs of a predetermined agenda take a special strain of a herbivorous animal and feed it large amounts of a substance it has never evolved to properly metabolize. Plant foods contain bugger all carnitine – the only meaningful source is animal flesh. So when you take an animal that has never developed the mechanisms to efficiently metabolize carnitine, it’s hardly surprising that pathological changes might occur after carnitine feeding.
This is the very same reason why feeding cholesterol – also found only in animal foods – has repeatedly produced ‘atherosclerosis’ in herbivorous lab animals over the years, but has completely failed to induce atherosclerosis in carnivorous animals. The former never evolved to efficiently metabolize cholesterol, while the latter did so on a daily basis. Dogs, for example, simply will not show any pathological changes in their arteries after being fed cholesterol unless you surgically remove their thyroids (again, I discuss this all in detail in The Great Cholesterol Con).

Now once again, let’s all stop and engage in one of those reflective moments where you angle your head slightly upwards and to the side and look like you’re deep in philosophical thought. But instead of pondering life’s deeper mysteries, I want you to simply ask yourself this:

If cholesterol feeding cannot induce atherosclerosis in meat-eating animals no matter how hard researchers try, why keep up the charade? Why the $#@% rip out the thyroid glands of man’s best friend? If they need to disfigure such beautiful and loyal creatures, shouldn’t that in itself tell them the cholesterol theory is utter bullshit? At what point do these researchers finally acknowledge reality, give up the cholesterol wank, and go searching for the real causes of heart disease?!
And you thought I was being overly misanthropic when I said the world was full of morons…
Anyways, back to our carnitine-fed mice. Did I mention that these were Apoe−/− mice?
What the bleep are Apoe−/− mice, I hear you asking?

Apoe−/− mice are specially bred mice that spontaneously develop ‘atherosclerotic lesions’ on a standard chow diet. If they develop arterial plaque like there’s no tomorrow on mice chow, what do you think is going to happen when they are supplemented an essentially foreign substance like carnitine?

Duh!

When the mice were given an oral antibiotic “cocktail” to wipe out their intestinal flora, in addition to l-carnitine, they showed marked reductions in plasma TMA and TMAO concentrations and no increase in atherosclerosis.

But so what? This still doesn’t change the fact that they are likely to metabolize carnitine very differently to humans. Proof of this comes from the researchers’ own initial studies with mice. This is where they gave them carnitine then cut them open to examine the bacterial compsition of their intestinal tract. They found “several bacterial taxa whose proportion was significantly associated (some positively, others inversely) with dietary l-carnitine and with plasma TMA or TMAO concentrations”.

However

“…a direct comparison of taxa associated with plasma TMAO concentrations in humans versus in mice failed to identify common taxa. These results are consistent with prior reports that microbes identified from the distal gut of the mouse represent genera that are typically not detected in humans”.

In other words, my contention that this strain of mice metabolizes carnitine differently than humans is not just theoretical musing – it’s a plain fact.

Not fussed by yet another self-contradiction to their untenable anti-carnitine theory, the researchers continue on with their mice shenanigans. Rather than admitting their results have little real life applicability to humans, they instead seek to find a “mechanism” for the carnitine-induced atherosclerosis seen in the Apoe−/− mice.

They observed that both carnitine and choline inhibited what is known as reverse cholesterol transport, which basically refers to the removal of cholesterol from tissues into the bloodstream and back to the liver. To understand why this is significant, we have to ponder for a moment the grade-school mentality towards cholesterol that dominates the medical and science fields nowadays. When the cholesterol theory first started showing signs of self-contradiction many moons ago, researchers quickly went into salvage mode by claiming it wasn’t just total cholesterol that mattered, but the ratio of LDL:HDL. They labelled LDL the “bad” cholesterol because it took cholesterol to the tissues. I guess the fact that our tissues sorely need cholesterol and we’d be royally screwed if they didn’t get it never crossed their minds. Bottom line, appearing on the cover of Time magazine or receiving Nobel prizes in no way guarantees you have a clue what you’re on about. There is nothing “bad” about LDL – it serves a vital function in our bodies and we’d be in a really bad place without it.
But let’s continue on…

Next, they dubbed HDL the “good” cholesterol because that was the lipoprotein that carried cholesterol away from the tissues and back to the liver where it was broken down into bile.
And so was born the ridiculously simplistic good cholesterol/bad cholesterol charade, which like the total cholesterol theory is a complete and utter wank. Studies have repeatedly shown that LDL does not cause atherosclerosis nor heart disease, something I discuss at length in my LDL paper.

So researchers then latched onto the oxidized LDL theory, again using the childishly simplistic logic that the higher your LDL, the higher your oxidized LDL.

And again, it was complete nonsense. While oxidized LDL may indeed be harmful, it has no relationship with your levels of total or LDL cholesterol. Rather, poor antioxidant status and disordered blood sugar control are the main culprits. Again, I discuss this in my LDL paper which you can access free of charge thanks to the good folks at JPANDS right here.

Oh, and remember how the researchers also observed that the nutrient choline inhibited reverse cholesterol uptake? Well, notice how they remain silent about that, and focus their hate campaign on carnitine which, unlike choline, is found mainly in red meat?

What they would be well aware of, but have chosen to ignore, is that carnitine-containing red meat is hardly the only food that raises TMA levels nor does it even come close to being the food that causes the greatest spike in TMA levels.

Guess which food causes the greatest hike in TMA levels?

Fish.

Yep, heart-healthy fish.

Thanks to a condition known as trimethylaminuria, whose unfortunate sufferers experience ‘‘fish-odour syndrome’’, numerous researchers have investigated the potential TMA-raising effects of choline and choline precursors and, more recently, actual foods.

Some especially insightful findings come from scientists at the Imperial College in London, who examined the urine of healthy male volunteers fed 30 different foods. Not all at once, of course. Instead, on separate occasions the volunteers consumed a 227 g serving of the foodstuff under investigation along with a standardized breakfast.

Beef ingestion resulted in negligible amounts of urinary TMA: a mere 20µg trimethylamine/g food, less than that seen for bread, carrots, cauliflower, cabbage, mushroom, peas, and potatoes. Lamb, by far the richest dietary source of carnitine, returned a score of 16.4µg.

In stark contrast, prawns, mackeral and cod delivered urinary TMA levels of 948, 679, and 1335µg trimethylamine/g food, respectively!

A previous paper by the same researchers also reported combined urinary levels of TMA+TMAO and found similar results. Beef and lamb produced lower urine levels of TMA+TMAO than the overwhelming majority of vegetables, all fish and seafood products, cheese, and eggs.

This previous paper also reported the effect of oral ingestion of betaine (1.76 g), carnitine (2.97 g), choline (2.10 g), creatinine (1.70 g), lecithin (11.65 g) and TMAO (1.67 g) on six separate occasions. Betaine, creatinine, and lecithin all failed to raise urinary TMA+TMAO levels. TMAO, not surprisingly, produced the highest levels, followed by choline. Carnitine, meanwhile, was converted to TMA+TMAO at only half the rate of choline (30.6% vs 62.9%, respectively).

Now let’s get back to the Nature Medicine paper. The researchers wanked on and on about red meat, but made no effort to investigate other foods, even though many other foodstuffs have already been documented to produce much higher TMA and TMAO increases than red meat. Based on the results of previous research, if we are going to make the extraordinary claim that carnitine-rich red meat causes heart disease due to its effects on TMA/TMAO levels, then for the sake of consistency we also need to claim that a far higher risk is posed by choline, most vegetables and all seafood.

Such a claim, of course, would be ridiculous. So the researchers simply ignored the inconvenient choline, vegetable and seafood data, and went about constructing a case against red meat.
Can you say preconceived agenda?

Summing It All Up So Far
So what we have is a study which used misrepresented epidemiology, blatant cherry-picking and a singles bar attitude to metabolomics as a springboard to validate what strongly looks like a preconceived agenda to implicate red meat and carnitine in the pathogenesis of heart disease.
This validation rests heavily on studies with a genetically modified strain of a herbivorous creature that is 0.001 the size of adult humans who follow omnivorous diets and have done so for millions of years. Despite the stark differences between the two species, this idiotic comparison is now being used to claim carnitine causes heart disease and to scare people away from both red meat and carnitine.

In further justification of their absurd theory, the researchers cite the allegedly lower CVD risk enjoyed by vegetarians and vegans. I recently explained in detail why the claim vegetarian/vegan diets confer protection against heart disease is yet another example of anti-science at its finest, propagated by people with an anti-meat agenda:

Vegetarian Diets Reduce Heart Disease? Nonsense!

The researchers even cite the Lyon Diet Heart Study in support of their theory, noting the subjects were instructed to eat less red meat. Yes, but they were also instructed to eat more fruits and vegetables and supplied with a special omega-3-rich spread. Blood testing showed both their serum antioxidant and omega-3 levels were increased; no such information was available for carnitine or TMA/TMAO.

The sad reality is that the Nature Medicine paper is one of the most poorly conceived pieces of rot I’ve had the misfortune of reading in a long, long time.

Rocky-1-meatworks
Ah, the good old days. When men were men, worked real jobs instead of playing with their statistics, and beat fresh carcasses in their pursuit of physical excellence.

Why Carnitine is Your (Very Good) Friend
Okay, I think we’ve well established that the methodology and reasoning in the Nature Medicine paper is dodgier than a drug-dealing loan-shark who also dabbles in used car sales.
What we’re now going to do is examine even more evidence the Nature Medicine researchers blatantly ignored – evidence not only showing carnitine does not cause cardiovascular disease, but may in fact benefit it.

I must say, I was shocked when I first heard about the current anti-carnitine hate campaign. I’ve read a lot about this amino acid over the years and have only ever been able to discover good things about it. So why on Earth were they picking on this beautiful, energy-providing amino acid, I wondered?
Like cholesterol, there is nothing “bad” about carnitine. Like cholesterol, it performs crucial functions in the body and if someone were to shove a carnitine-specific vacuum up your keester and completely suck this crucial amino acid from your body, you’d find yourself in a whole heap of trouble, real quick.

Carnitine is found in nearly every cell in your body, and plays a critical role in energy production. And when I say critical, I really do mean critical. It transports fatty acids into the “engines” of your cells – the mitochondria – so they can be oxidized to produce energy. Some very unfortunate folks suffer from a condition known as primary carnitine deficiency, a genetic disorder that interferes with cellular carnitine transport. This condition usually manifests itself by five years of age, and common symptoms include cardiomyopathy (which in turn increases the risk of heart failure), skeletal-muscle weakness, and hypoglycemia.

Carnitine also transports toxic compounds generated during energy production out of the mitochondria to prevent their accumulation. Yep, carnitine is one hell of a compound; it fuels your cellular engines and cleans them at the same time. The physiological equivalent of BP Ultimate, if you will.

Thanks to its critical role in fat-derived energy production, carnitine is concentrated in tissues like skeletal and heart muscle where fatty acids constitute a vital fuel source.

While muscles also rely heavily on carbohydrate (save me the “fat adaptation” speech, oh ye flabby low-carbers who bonk ten minutes into a strenuous ride), the heart relies primarily on fatty acids even when you consume a high-carb diet.

Are you beginning to see why I hold the anti-carnitine authors and the screwball journalists who uncritically soaked up their nonsense with such contempt? If the world listens to these maniacs and embarks on an anti-carnitine campaign, we will much more likely see an increase in heart disease, rather than a decrease. Not to mention a marked decline in overall health and well being.
Bold claim?

Not at all.

The Evidence they Ignored
We discussed how the researchers chose a specially bred strain of mice to prove their point that carnitine promotes atherosclerosis. Having obtained the results they were after, they then engage in some highly questionable extrapolation to incriminate carnitine as doing the same thing to humans.
Well, guess what? This was hardly the first time researchers had fed carnitine to herbivorous animals.
And guess what else? Yep, they obtained results starkly different to those reported in the Nature Medicine paper. Not surprisingly, that paper does not so much as mention these conflicting studies.

Here are just a few:
Spanish researchers took mice bred to be especially prone to obesity and fed them a high-fat diet for nine weeks, during which time they suffered reduced cardiac output, worsening arterial function, deteriorating glycemic control, and decreased tissue production of nitric oxide (the gas that helps keep your arteries supple and elastic). During the subsequent four weeks, they divided the mice into 2 groups. One group continued to receive plain water, while the other group’s drinking water was supplemented with carnitine (200 mg/kg/day). The carnitine-enhanced water improved cardiac output, arterial function, insulin resistance and increased nitric oxide levels. Plain water had no effect.
Egyptian researchers deliberately made rabbits hypercholesterolemic by feeding them cholesterol (again, unlike humans they aren’t equipped to properly process cholesterol, and dietary ingestion quickly raises their blood levels). They then made them carnitine deficient, and observed severe atherosclerotic lesions, intimal plaques and foam cell formation. Daily administration of L-carnitine (250 mg/kg), for 28 days, completely prevented the progression of atherosclerotic lesions in both aorta and coronary arteries.

Italian researchers similarly found that rabbits on a cholesterol-enriched diet who were supplemented with l-carnitine experienced a “decrease of plaque cell proliferation and severity of aortic atherosclerotic lesions.”[5]

So even in other strains of mice and in rabbits, other researchers have found no adverse effect of carnitine and in fact have found beneficial effects!

But that’s in animals. What cardiovascular effects does supplemental carnitine have in humans?

The Italians: Not Just Hot Curvy Babes and Hot Curvy Cars
The Italians have performed a lot of research on both l-carnitine and acetyl-l-carnitine, and their work is crying out to be replicated by other groups (of course, if carnitine were a patentable drug, this replication would have happened long ago). As far back as the 1970s and 1980s, they had reported l-carnitine improved exercise tolerance, reduced infarct size in heart attack patients, and reduced post-cardiac event mortality at one and six months.

Inspired by these early results, in 1992 Italian researchers published the results of a carnitine intervention trial involving 160 recent heart attack victims. This was a non-blinded trial in which patients were randomly assigned to 4 grams daily of carnitine in addition to their usual medication, or to a group which received their usual medication but no supplemental carnitine. After one year, there were ten deaths in the control group (8 due to cardiovascular causes) but only one in the carnitine group (due to thromboembolism).

In addition to greatly lowered mortality risk, the patients in the carnitine group also enjoyed improvements in heart rate and blood pressure, and a reduction of angina attacks, rhythm disorders, and signs of impaired heart muscle contractility[7].

Another group of Italian researchers took thirty-eight elderly patients suffering heart failure, and randomly assigned them to receive either l-carnitine or placebo in addition to their usual medical care. The dose was 1g twice daily, for 45 days. Those receiving carnitine experienced greater ECG improvements and a marked reduction in their daily digitalis requirement. No adverse reactions to carnitine were observed in any of the patients[8].

These were small, short studies; to see if they could be replicated in a larger, double-blind trial, a larger Italian study was commenced. This study, published in 2005, aimed to determine the effect of L-carnitine in patients presenting to cardiology units with heart attack. In those receiving carnitine, the amino acid was delivered at a dose of 9 grams intravenously for the first 5 days, then then 4 grams per day orally for the next 6 months. The researchers had originally planned to include 4,000 patients with acute anterior myocardial infarction, but lower than expected numbers of eligible patients meant only 2,330 patients participated.

During the first 5 days, patients receiving the high-dose IV carnitine enjoyed a significantly lower rate of mortality. During the remainder of the study, this advantage dissipated; at 6 months, the carnitine group showed a non-significant 14% relative reduction in the combined occurrence of death and heart failure, and a non-significant 12% lower overall mortality.

Disappointing, but hardly supportive of idiotic claims that “Carnitine Causes Heart Disease!”
Hopefully researchers will keep studying the cardiovascular effects of carnitine, and hopefully not in isolation but in conjunction with other critical and potentially synergistic nutrients such as taurine, CoQ10 and even creatine. All of which, by the way, are only found in animal products (hmmm, I wonder how long will it take for some nutty research crew to come out and claim they are also bad for your heart…)

There’s been a whole bunch of studies examining the effect of effect of carnitine on walking distance in patients with peripheral arterial disease. Researchers at Adelaide’s Flinders University recently conducted a review of this research and found “Most trials demonstrated a small or modest improvement in walking performance with administration of PLC [propionyl-l-carnitine] or l-carnitine. These findings were largely independent of level or quality of evidence, while there was some evidence that intravenous administration was more effective than oral administration and those with severe claudication may achieve greater benefits than those with moderate claudication.”
They also noted in their conclusion, “Routine carnitine supplementation in the form of PLC may therefore be a useful adjunct therapy for management of intermittent claudication.”[9]
Carnitine has also been shown to benefit, of all things, erectile dysfunction. Yep, researchers recruited a bunch of aging Italian ex-Stallions and then randomized them to either 4 grams daily of carnitine (2g acetyl-l-carnitine + 2g propionyl-l-carnitine), 160mg testosterone undecanoate, or placebo for 6 months. During the six months of the study, the carnitine combo proved significantly more effective than testosterone undecanoate in improving “nocturnal penile tumescence“, which is science-speak for nighttime boners. Carnitine was also significantly more effective for improving scores on the International Index of Erectile Function (yes, they have an international index for this kind of thing).

A year later, the same researchers published the results of another study involving patients who underwent prostatectomy. They compared sildenafil, sildenafil plus the aforementioned carnitine mix, or placebo. The carnitine+sildenafil group scored significantly better than sildenafil-only patients for erectile function, sexual intercourse satisfaction, orgasm, and general sexual well-being. Only the carnitine+sildenafil group had a significantly increased percentage of patients with a positive intracavernous injection test (please don’t ask me to describe what that involves…)
A more recent Italian study examined supplementation with propionyl-L-carnitine, L-arginine and niacin and sexual performance among men presenting to an erectile dysfunction clinic. After three months of treatment, a small but statistically significant improvement in total and individual items of the International Index of Erectile Function was found. Analyses of global assessment questions answered by the patients revealed the nutrient trio improved erections in 40% of cases, with a partial response occurring in up to 77% of subjects enrolled.

L-carnitine: Critical for your ticker, good for your pecker too!

In Closing…
If I haven’t convinced you by now that the study behind the current carnitine hating is complete and utter horseshit, then nothing will. For the rest of you that haven’t recently undergone a lobotomy, it’s important you start standing up to this kind of rot. This is serious business folks. Googling around, I see this study has received immense worldwide coverage while very few rebuttals have been posted, despite the fact it is patently absurd nonsense.

In recent times there seems to be an intensifying of research efforts, no matter how ridiculous, aimed at vilifying perfectly natural and wholly nutritious animal foods (see my article on the atrocious anti-egg research of Canadian trio Spence et al here, and the recent claim that vegetarian diets reduce heart disease here).

I’m not sure what the endgame is here. Some folks out there are convinced this growing anti-animal food crusade is part of some wider conspiracy, something I’m simply not placed to endorse nor refute. And while some of you are no doubt snickering and making jokes about tin foil hats, I will point out the following: Anyone who’s read Marvin Harris’ truly brilliant Cannibals and Kings will know this would hardly be the first time in history the powers-that-be have instigated and nurtured efforts to vilify certain types of meat in order to fulfill ulterior motives.

Regardless of whether or not a bunch of wealthy oligarchical assholes are covertly trying to manipulate our perceptions of certain foods, I sincerely doubt garden-variety research teams are a knowing part of any such agenda. Far more likely and ubiquitous explanations are the power of conformity, the desire for recognition, and financial gain.

In the “Contributions” section of the Nature Medicine paper (which can be viewed by clicking here and scrolling down) we learn “S.L.H. [co-author Stanley Hazen] conceived of the idea, helped design the experiments, provided the funding for the study and helped draft and critically revise the manuscript”.

Scrolling further down and taking a quick look at the competing financial interests of the authors reveals the usual links to drug companies and research outfits that profit handsomely from the cholesterol sham:

“Z.W. [Zeneng Wang] and B.S.L. [Bruce Levinson] are named as co-inventors on pending patents held by the Cleveland Clinic relating to cardiovascular diagnostics and have the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics from Liposciences. W.H.W.T. received research grant support from Abbott Laboratories and served as a consultant for Medtronic and St. Jude Medical. S.L.H. [Stanley Hazen] and J.D.S. are named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics patents. S.L.H. has been paid as a consultant or speaker by the following companies: Cleveland Heart Lab., Esperion, Liposciences, Merck & Co. and Pfizer. He has received research funds from Abbott, Cleveland Heart Lab., Esperion and Liposciences and has the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics from Abbott Laboratories, Cleveland Heart Lab., Frantz Biomarkers, Liposciences and Siemens.”
But my eyebrows were raised when I read about “patents” and “royalty payments…relating to cardiovascular diagnostics”. So I jumped onto Google and promptly discovered the following patent application: “TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF DISEASE

The applicant is seeking a patent for TMA tests that will purportedly determine whether people are at risk of developing CVD, diabetes, insulin resistance, metabolic syndrome, or fatty liver.
The applicant/owner of the patent is none other than The Cleveland Clinic Foundation, and the listed inventors are, lo and behold, Stanley Hazen, Bruce Levison, and Zeneng Wang.

And so we now see a potentially very lucrative income stream for these researchers if their carnitine/red meat/TMA/heart disease charade gains traction. Again, this kind of information gets left out of the hyperbolic fanfare accompanying the release of these types of studies, and it’s left up to people like me – you know, living out here in “left field” sipping Dom Pérignon in our jaccuzzis, being pampered by half our supermodel harems while the other half washes our collection of exotic supercars out on our imported Italian marble driveways - to point out the absurdities and blatant conflicts of interest in these intelligence-assaulting studies.

Folks, stand up to stupid…it really isn’t that hard.

Otherwise, in 20 years time, billions of your (and your children’s) taxpayer dollars are going to be handed over to clueless researchers attempting to uncover the ‘paradox’ of why red meat consumption has dramatically diminished yet heart disease still remains our number one killer, along with an ‘unexplained’ increase in anemia and chronic fatigue…

Related and Recommended Reading:

*Please note AnthonyColpo.com does not condone reckless driving on public roads. If the author was wealthy enough to own and thrash a Lamborghini, he would most assuredly do it on a racetrack. Or in a muddy paddock. Now that would be fun. Or maybe the giant car park next to Bunnings at…uh, never mind.

Disclosure Statement: The author of this article has absolutely no relationship, financial or otherwise, with the meat, dairy, or egg industries. The author does, however, eat red meat on a regular basis because it makes him feel much more energetic, rosy-cheeked and downright manly compared to that terribly misguided period long, long ago where he obtained most of his protein from fish and chicken.
References
1. Onder G, et al. Serum cholesterol levels and in-hospital mortality in the elderly. American Journal of Medicine, Sep, 2003; 115 (4): 265-271.
2. Horwich TB, et al. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. American Heart Journal, Dec, 2008; 156 (6): 1170-1176.
3. Stachon A, et al. Prognostic Significance of Low Serum Cholesterol after Cardiothoracic Surgery. Clinical Chemistry, 2000; 46 (8): 1114–1120.
4. Spinar et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Critical Care, 2011; 15: R291.
6. Spagnoli LG, et al. Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis, Apr 7, 1995; 114 (1): 29-44.
7. Davini P, et al. Controlled study on L-carnitine therapeutic efficacy in post-infarction. Drugs Under Experimental And Clinical Research, 1992; 18: 355-365.
8. Ghidini O, et al. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure. International Journal of Clinical Pharmacology, Therapy and Toxicology, Apr, 1988; 26 (4): 217-220.
9. Delaney CL, et al. A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication. Atherosclerosis. 2013 Mar 15. pii: S0021-9150(13)00179-2. doi: 10.1016/j.atherosclerosis.2013.03.004. [Epub ahead of print]

Anthony Colpo is an independent researcher, physical conditioning specialist, and author of The Fat Loss Bible and The Great Cholesterol Con. For more information, visit TheFatLossBible.net or TheGreatCholesterolCon.com
=====================================================================
Read the complete article here.